These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 9031792)

  • 1. Development of malignant melanoma after repeated topical photodynamic therapy with 5-aminolevulinic acid at the exposed site.
    Wolf P; Fink-Puches R; Reimann-Weber A; Kerl H
    Dermatology; 1997; 194(1):53-4. PubMed ID: 9031792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of squamous cell carcinoma after photodynamic therapy with methyl aminoleuvulinate.
    Calista D
    Br J Dermatol; 2014 Oct; 171(4):905-8. PubMed ID: 24702060
    [No Abstract]   [Full Text] [Related]  

  • 3. Erosive pustular dermatosis of the scalp following topical methylaminolaevulinate photodynamic therapy.
    Guarneri C; Vaccaro M
    J Am Acad Dermatol; 2009 Mar; 60(3):521-2. PubMed ID: 19231656
    [No Abstract]   [Full Text] [Related]  

  • 4. Development of a keratoacanthoma after topical photodynamic therapy with 5-aminolevulinic acid.
    Maydan E; Nootheti PK; Goldman MP
    J Drugs Dermatol; 2006 Sep; 5(8):804-6. PubMed ID: 16989196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aminolevulinic acid (Levulan) in photodynamic therapy of actinic keratoses.
    Lang K; Schulte KW; Ruzicka T; Fritsch C
    Skin Therapy Lett; 2001 Sep; 6(10):1-2, 5. PubMed ID: 11685275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical photodynamic therapy in clinical dermatology.
    Kormeili T; Yamauchi PS; Lowe NJ
    Br J Dermatol; 2004 Jun; 150(6):1061-9. PubMed ID: 15214890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical photodynamic therapy with endogenous porphyrins after application of 5-aminolevulinic acid. An alternative treatment modality for solar keratoses, superficial squamous cell carcinomas, and basal cell carcinomas?
    Wolf P; Rieger E; Kerl H
    J Am Acad Dermatol; 1993 Jan; 28(1):17-21. PubMed ID: 8318069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alopecia of the scalp after ineffective treatment of Bowen's disease using red light 5-aminolevulinic acid photodynamic therapy: two case reports.
    Letada PR; Uebelhoer NS; Masters R; Satter EK; Shumaker PR
    Dermatol Surg; 2010 Nov; 36(11):1786-9. PubMed ID: 20961355
    [No Abstract]   [Full Text] [Related]  

  • 9. Letter: photodynamic therapy with methyl aminolevulinate induces phototoxic reactions on areas of the nose adjacent to basal cell carcinomas and actinic keratoses.
    Toll A; Parera ME; Vélez M; Pujol RM
    Dermatol Surg; 2008 Aug; 34(8):1145-7; discussion 1147-8. PubMed ID: 18518890
    [No Abstract]   [Full Text] [Related]  

  • 10. Long-term efficacy and safety of daylight photodynamic therapy with methyl amninolevulinate for actinic keratosis of the face and scalp.
    Fargnoli MC; Piccioni A; Neri L; Tambone S; Pellegrini C; Peris K
    Eur J Dermatol; 2017 Feb; 27(1):89-91. PubMed ID: 27748261
    [No Abstract]   [Full Text] [Related]  

  • 11. Aminolevulinic acid and photodynamic combination therapy in the treatment of actinic keratoses: caring for the patient.
    Harvie SE
    Dermatol Nurs; 2007 Feb; 19(1):31-4, 39. PubMed ID: 17330552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methyl aminolevulinate: actinic keratoses and Bowen's disease.
    Morton CA
    Dermatol Clin; 2007 Jan; 25(1):81-7. PubMed ID: 17126745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methyl-aminolevulinate photodynamic therapy for the treatment of actinic keratoses and non-melanoma skin cancers: a retrospective analysis of response in 462 patients.
    Fai D; Arpaia N; Romano I; Vestita M; Cassano N; Vena GA
    G Ital Dermatol Venereol; 2009 Jun; 144(3):281-5. PubMed ID: 19528909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcutaneous electrical nerve stimulation for pain relief during photodynamic therapy of actinic keratoses.
    Halldin CB; Paoli J; Sandberg C; Ericson MB; Wennberg AM
    Acta Derm Venereol; 2008; 88(3):311-3. PubMed ID: 18480950
    [No Abstract]   [Full Text] [Related]  

  • 15. Late erythema after photodynamic therapy to the face.
    Misra A; Maybury K; Eltigani TA
    Plast Reconstr Surg; 2006 Jun; 117(7):2522-3. PubMed ID: 16772986
    [No Abstract]   [Full Text] [Related]  

  • 16. Photodynamic therapy with aminolevulinic acid topical solution and visible blue light in the treatment of multiple actinic keratoses of the face and scalp: investigator-blinded, phase 3, multicenter trials.
    Piacquadio DJ; Chen DM; Farber HF; Fowler JF; Glazer SD; Goodman JJ; Hruza LL; Jeffes EW; Ling MR; Phillips TJ; Rallis TM; Scher RK; Taylor CR; Weinstein GD
    Arch Dermatol; 2004 Jan; 140(1):41-6. PubMed ID: 14732659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute phototoxicity with urticarial features during topical 5-aminolaevulinic acid photodynamic therapy.
    Kerr AC; Ferguson J; Ibbotson SH
    Clin Exp Dermatol; 2007 Mar; 32(2):201-2. PubMed ID: 17244343
    [No Abstract]   [Full Text] [Related]  

  • 18. Rapid development of squamous cell carcinoma after photodynamic therapy.
    Liang WM; Theng TS; Lim KS; Tan WP
    Dermatol Surg; 2014 May; 40(5):586-8. PubMed ID: 24858258
    [No Abstract]   [Full Text] [Related]  

  • 19. Peripheral facial palsy after topical photodynamic therapy for facial actinic keratoses.
    Gemigniani F; Bodet D; González-Llavona B; García-Patos V
    J Am Acad Dermatol; 2014 Sep; 71(3):e90-2. PubMed ID: 25128142
    [No Abstract]   [Full Text] [Related]  

  • 20. Cellulitis as a postprocedural complication of topical 5-aminolevulinic acid photodynamic therapy in the treatment of actinic keratosis.
    Wolfe CM; Hatfield K; Cognetta AB
    J Drugs Dermatol; 2007 May; 6(5):544-8. PubMed ID: 17679192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.